The “digital twins” helped doctors spot good targets for heart ablation in 10 patients. Months later, all of them are free of sustained faulty rhythms.
This postdoctoral researcher uses chemogenetic tools to investigate how cellular oxidants act as molecular messengers in the brain and cardiovascular system.